Investor Overview

Investor Relations

The success of St. Jude Medical depends on our ability to invent medical devices that help improve patient outcomes and reduce the cost of health care. We invest more than 12 percent of revenue in medical device innovation every year and our product portfolio reflects a cumulative investment in medical device innovation totaling more than $10 billion.

Read More
NYSE: STJ $ 62.49 +0.45 ( +0.72% ) Volume: 2,818,292 stock details > April 17, 2014

Contact Investor Relations

J.C. Weigelt Director, Investor Relations St. Jude Medical, Inc. One St. Jude Medical Drive St. Paul, MN 55117 651-756-4347 JWeigelt@sjm.com
All Contacts

Email Signup

Email Address *
Mailing Lists *